Malignant Hypercalcemia Induced by the Ectopic Production of Intact Parathyroid Hormone (PTH).

ectopic malignant hyperparathyroidism ectopic pth production intact parathyroid hormone malignant hypercalcemia small cell lung cancer

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Feb 2023
Historique:
accepted: 08 02 2023
entrez: 13 3 2023
pubmed: 14 3 2023
medline: 14 3 2023
Statut: epublish

Résumé

Malignant hypercalcemia is a common finding in patients with advanced cancer, involving mechanisms like tumor secretion of parathyroid hormone (PTH)-related protein, osteolytic metastases, and tumor production of calcitriol. Although rare, hypercalcemia induced by ectopic tumoral secretion of PTH can be an additional mechanism. Here we present an 84-year-old male patient who was admitted to the hospital with a non-productive cough, anorexia, and a single episode of small-volume hemoptysis. He was diagnosed with stage T4N3M1c left lung small cell carcinoma, and laboratory tests were remarkable for elevated ionized calcium as well as elevated serum intact PTH. A parathyroid 99mTc sestamibi scan showed no changes, suggesting ectopic production of PTH. Being a rare event, malignant hypercalcemia from intact PTH ectopic production should be considered in these patients.

Identifiants

pubmed: 36909108
doi: 10.7759/cureus.34770
pmc: PMC10001420
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e34770

Informations de copyright

Copyright © 2023, Neves et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Clin Endocrinol Metab. 1994 Sep;79(3):912-5
pubmed: 8077382
N Engl J Med. 1990 Nov 8;323(19):1324-8
pubmed: 2215618
J Clin Endocrinol Metab. 2006 Feb;91(2):580-3
pubmed: 16263810
Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):339-46
pubmed: 21897221
J Clin Endocrinol Metab. 1998 Aug;83(8):2653-7
pubmed: 9709927
Endocr Pract. 2004 Mar-Apr;10(2):125-8
pubmed: 15256329
J Endocr Soc. 2017 May 03;1(6):691-711
pubmed: 29264523
Endocrine. 2005 Jun;27(1):83-6
pubmed: 16077176
J Thorac Oncol. 2016 Jan;11(1):39-51
pubmed: 26762738
Arch Intern Med. 1978 Aug;138(8):1290-1
pubmed: 677991
Curr Med Chem. 2011;18(23):3462-7
pubmed: 21756237
J Med Assoc Thai. 2007 Apr;90(4):663-71
pubmed: 17487119
Medicine (Baltimore). 1980 Jul;59(4):262-82
pubmed: 6993843
Ann Transl Med. 2019 Aug;7(15):359
pubmed: 31516905
J Clin Endocrinol Metab. 1996 Oct;81(10):3793-6
pubmed: 8855839
N Engl J Med. 1983 Aug 11;309(6):325-30
pubmed: 6866067
J Clin Endocrinol Metab. 1993 May;76(5):1373-5
pubmed: 7684395
J Clin Endocrinol Metab. 1989 May;68(5):976-81
pubmed: 2541161

Auteurs

Ana Neves (A)

Internal Medicine, Centro Hospitalar Universitário de São João, Porto, PRT.

Inês Mendonça (I)

Intensive Care Medicine, Centro Hospitalar Universitário de São João, Porto, PRT.

José Alberto Cunha Marques (JA)

Internal Medicine, Centro Hospitalar Universitário de São João, Porto, PRT.

José Costa (J)

Internal Medicine, Hospital Terras do Infante, Lagos, PRT.

Jorge S Almeida (JS)

Medicine, Faculdade de Medicina da Universidade do Porto, Porto, PRT.
Internal Medicine, Centro Hospitalar Universitário de São João, Porto, PRT.

Classifications MeSH